Tien Liang BioTech Co., Ltd. (4127.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan
Price
33.00 TWD
Market cap
1.51 bn TWD
P/E (2025)
–
P/S (2025)
2.95
Dividend yield
0.00 %
Net margin
-2.00 %
Return on equity (ROE)
-2.16 %
Return on assets (ROA)
-0.87 %
Tien Liang BioTech Co., Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 385.21 m TWD | 511.79 m TWD |
| Gross profit | 229.91 m TWD | 287.94 m TWD |
| Operating income | 593,000.00 TWD | -16.14 m TWD |
| EBIT | 16.18 m TWD | -621,000.00 TWD |
| Net income | 11.70 m TWD | -10.25 m TWD |
| Diluted EPS – continuing operations | 0.25 TWD | -0.22 TWD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Tien Liang BioTech Co., Ltd.
Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan. The company offers Chinese and Western medicine, other healthcare, and cosmetic products through online and offline channels. Tien Liang BioTech Co., Ltd. was founded in 1971 and is based in New Taipei City, Taiwan.
More stocks
- Aplex Technology (6570.TWO)
- Soma Gold Corp (SOMA.V)
- Leef Brands Inc. (LEEEF)
- Dong-A Hwa Sung Co.Ltd (041930.KQ)
- XCF Global, Inc. (SAFX)
- Northwest Copper Corp (NWST.V)
- KISTRON Co., Ltd. (475430.KQ)
- Actinium Pharmaceuticals, Inc. (ATNM)
- Aura Energy Ltd (AEE.AX)
- LumenRadio AB (LUMEN.ST)
- Rubicon Technology Inc (RBCN)
- OSE Pharma SA (OSE.PA)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.